Talking Medicines in Transformation Partnership

Glasgow, Scotland-based pharma sector social media intelligence company Talking Medicines has partnered with consultancy Closing Delta, to help marketers accelerate their digital transformation plans.

Talking Medicines offers AI-driven patient social media intelligence specifically for the pharmaceutical industry. Last year, the firm secured £1.1m in funding, to support the launch and roll-out of its PatientMetRx, which captures the voice of the patient from millions of online sources and provide drug companies with a way to measure patients' experiences of taking medicines.

Closing Delta was set up by former Boehringer Ingelheim exec Gaurav Sanganee. The partnership will bring together social media insights into what patients are saying about their medicines, with digital transformation consultancy and support. The combined offering aims to improve the marketing performance of medicine brands, and develop patient outcomes.

Talking Medicines CEO Jo Halliday says digital transformation in the pharmaceutical industry is crucial for improved patient care, cost-effectiveness, greater transparency, improved production and drug development, but also crucial to pharma's patient-centricity ambitions. She adds: 'Until now, pharma has lacked the ability to effectively listen to what patients are saying about their medicines online and make sense of all that data. We look forward to working closely with Gaurav and his team to support brands in measuring and transforming patient experience through enhanced digital insights'.

Web sites: www.talkingmedicines.com and www.closingdelta.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.